USE OF A LACTOFERRIN ASSAY IN THE DIFFERENTIAL-DIAGNOSIS OF FEMALE GENITAL-TRACT INFECTIONS AND IMPLICATIONS FOR THE PATHOPHYSIOLOGY OF BACTERIAL VAGINOSIS

Citation
Mf. Rein et al., USE OF A LACTOFERRIN ASSAY IN THE DIFFERENTIAL-DIAGNOSIS OF FEMALE GENITAL-TRACT INFECTIONS AND IMPLICATIONS FOR THE PATHOPHYSIOLOGY OF BACTERIAL VAGINOSIS, Sexually transmitted diseases, 23(6), 1996, pp. 517-521
Citations number
26
Categorie Soggetti
Dermatology & Venereal Diseases","Infectious Diseases
ISSN journal
01485717
Volume
23
Issue
6
Year of publication
1996
Pages
517 - 521
Database
ISI
SICI code
0148-5717(1996)23:6<517:UOALAI>2.0.ZU;2-B
Abstract
Background and Objectives: Lactoferrin has served as a marker for leuk ocytes (polymorphonuclear neutrophils [PMN]) in clinical specimens. Go al: To investigate the potential of a lactoferrin latex agglutination test in the differential diagnosis of female genital infection. Study Design: Lactoferrin was quantified in the vaginal discharge of women w ith genital infections. Polymorphonuclear neutrophils were added to va ginal discharge and observed over 8 hours. Results: Vaginal lactoferri n titers were significantly elevated in women with trichomoniasis, can didiasis, and bacterial vaginosis (BV). Using a lactoferrin titer of g reater than or equal to 1:40, the assay has a sensitivity of 79.3% and a specificity of 83.3% for the presence of trichomoniasis or bacteria l vaginosis. Vaginal discharge from women with BV significantly destro yed added PMN. Conclusions: Vaginal lactoferrin determinations may pro vide a useful screen for inflammatory genital infections and identify individuals who require additional diagnostic evaluation. The observed absence of PMN in bacterial vaginosis may result from the destruction of PMN in vaginal discharge rather than the absence of a primary infl ammatory response.